What Brainstorm Cell Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 6 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,470,000 |
| Disposed | 0 | 0 |
| Net activity | +0 | +2,470,000 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Frenkel Jacob A | Director | Jul 24 | Grant / award · A | +100,000 | — | — | 343,777 |
| Arbel Irit | Director | Feb 26 | Grant / award · A | +120,000 | — | — | 161,054 |
| Frenkel Jacob A | Director | Feb 26 | Grant / award · A | +200,000 | — | — | 243,777 |
| Patlis Alla | See Remarks | Feb 26 | Grant / award · A | +100,000 | — | — | 144,349 |
| Yablonka Uri | EVP & Chief Business Officer | Feb 26 | Grant / award · A | +150,000 | — | — | 218,464 |
| Lebovits Chaim | President & CEO | Feb 26 | Grant / award · A | +1,800,000 | — | — | 2,000,960 |
| Lindborg Stacy | Director | Jan 01 | Grant / award · A | +20,000 | — | — | 48,229 |
| Arbel Irit | Director | Jan 01 | Grant / award · A | +30,666 | — | — | 41,054 |
| Hartounian Hartoun | EVP, Chief Operating Officer | Jan 01 | Grant / award · A | +50,000 | — | — | 52,000 |
| Bairu Menghisteab | Director | Jan 01 | Grant / award · A | +24,000 | — | — | 24,000 |
| Naor Nir | Director | Jan 01 | Grant / award · A | +30,666 | — | — | 31,465 |
| Patlis Alla | See Remarks | Jan 01 | Grant / award · A | +40,000 | — | — | 44,349 |
| Frenkel Jacob A | Director | Jan 01 | Grant / award · A | +40,000 | — | — | 43,777 |
| Yablonka Uri | EVP & Chief Business Officer | Jan 01 | Grant / award · A | +20,000 | — | — | 68,464 |
| Yablonka Uri | EVP & Chief Business Officer | Jan 01 | Grant / award · A | +40,000 | — | — | 48,464 |
| Polverino Anthony J. | Director | Jan 01 | Grant / award · A | +24,000 | — | — | 25,730 |
| Lebovits Chaim | President & CEO | Jan 01 | Grant / award · A | +120,000 | — | — | 200,960 |
| Dagher Ibrahim B. | Chief Medical Officer | Jan 01 | Grant / award · A | +50,000 | — | — | 66,849 |
| Lebovits Chaim | President & CEO | Oct 01 | Open-market buy · P | +1,836 | $3.43 | +$6.29K | 80,960 |
| Lebovits Chaim | President & CEO | Sep 30 | Open-market buy · P | +22,000 | $0.23 | +$5.02K | 1,186,865 |
Loading...
